Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer

Over the past decades, prognosis of advanced stage epithelial ovarian cancer remains very poor, despite the development of new chemotherapeutic drugs, as well as molecular targeted agents. Late presentation and frequent chemoresistance account for the poor prognosis. Emerging studies have shown that...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Dong Hoon, Kim, Mi-Kyung, Kim, Hee Seung, Chung, Hyun Hoon, Song, Yong Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189470/
https://www.ncbi.nlm.nih.gov/pubmed/25337550
http://dx.doi.org/10.15430/JCP.2013.18.3.227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189470/
https://www.ncbi.nlm.nih.gov/pubmed/25337550
http://dx.doi.org/10.15430/JCP.2013.18.3.227

Ejemplares similares